Kojic acid applications in cosmetic and pharmaceutical preparations.
Cosmetic
Health brightening products
Hyperpigmentation
Kojic acid
Melanin
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
20
09
2018
revised:
25
11
2018
accepted:
02
12
2018
pubmed:
12
12
2018
medline:
23
4
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
Skin color disorders can be caused by various factors, such as excessive exposure to sunlight, aging and hormonal imbalance during pregnancy, or taking some medications. Kojic acid (KA) is a natural metabolite produced by fungi that has the ability to inhibit tyrosinase activity in synthesis of melanin. The major applications of KA and its derivatives in medicine are based on their biocompatibility, antimicrobial and antiviral, antitumor, antidiabetic, anticancer, anti-speck, anti-parasitic, and pesticidal and insecticidal properties. In addition, KA and its derivatives are used as anti-oxidant, anti-proliferative, anti-inflammatory, radio protective and skin-lightening agent in skin creams, lotions, soaps, and dental care products. KA has the ability to act as a UV protector, suppressor of hyperpigmentation in human and restrainer of melanin formation, due to its tyrosinase inhibitory activity. Also, KA could be developed as a chemo sensitizer to enhance efficacy of commercial antifungal drugs or fungicides. In general, KA and its derivatives have wide applications in cosmetics and pharmaceutical industries.
Identifiants
pubmed: 30537675
pii: S0753-3322(18)36747-7
doi: 10.1016/j.biopha.2018.12.006
pii:
doi:
Substances chimiques
Antifungal Agents
0
Antioxidants
0
Cosmetics
0
Free Radical Scavengers
0
Melanins
0
Pyrones
0
kojic acid
6K23F1TT52
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
582-593Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.